Considering the anti-tuberculosis activity established in experiments in vitro and the safety of 3-[4-(2-fluorobenzoyl)piperazine-1-carbonyl]-N-[3-(trifluoromethyl)phenyl]benzamide established in experiments in vivo, this new synthesized compound can be considered promising for further research.